Market revenue in 2023 | USD 2,320.5 million |
Market revenue in 2030 | USD 3,502.2 million |
Growth rate | 6.1% (CAGR from 2023 to 2030) |
Largest segment | Large molecules |
Fastest growing segment | Small molecules |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Large Molecules, Small molecules |
Key market players worldwide | Boehringer Ingelheim, Catalent Inc, Baxter International Inc, Eurofins Scientific SE, Recipharm, Fresenius SE & Co KGaA, Novartis AG ADR, Recro Pharma, Symbiosis Pharmaceutical Services, MabPlex International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fill-finish pharmaceutical contract manufacturing market will help companies and investors design strategic landscapes.
Large molecules was the largest segment with a revenue share of 67.09% in 2023. Horizon Databook has segmented the Europe fill-finish pharmaceutical contract manufacturing market based on large molecules, small molecules covering the revenue growth of each sub-segment from 2018 to 2030.
The Europe fill-finish pharmaceutical contract manufacturing market is a significant and growing segment of the pharmaceutical industry. Europe is one of the largest markets for fill-finish contract manufacturing, accounting for a 24.9% of the global market.
There are several factors driving the growth of fill-finish pharmaceutical contract manufacturing market in Europe. One key factor is the increasing demand for biologics and biosimilars, which require specialized filling and packaging processes.
For instance, as per a report published by IQVIA in 2021, biologics accounted for 34% of medicine spending in Europe and were valued at USD 83.80 billion in 2021. Another factor is the growing trend of outsourcing pharmaceutical manufacturing, as companies seek to reduce costs and focus on core competencies.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe fill-finish pharmaceutical contract manufacturing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe fill-finish pharmaceutical contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account